donepezil has been researched along with DDPAC in 4 studies
Donepezil: An indan and piperidine derivative that acts as a selective and reversible inhibitor of ACETYLCHOLINESTERASE. Donepezil is highly selective for the central nervous system and is used in the management of mild to moderate DEMENTIA in ALZHEIMER DISEASE.
donepezil : A racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine.
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one : A member of the class of indanones that is 5,6-dimethoxyindan-1-one which is substituted at position 2 by an (N-benzylpiperidin-4-yl)methyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In terms of antidepressant drugs prescribed in hospital admission, during stay and discharge, the number of sertraline and venlafaxine prescriptions were associated with the number of VaD patients whilst the number of mirtazapine prescriptions was associated with frontotemporal dementia patients." | 4.12 | Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals. ( Finn, DP; Joshi, A; McClean, PL; Todd, S; Wong-Lin, K, 2022) |
| "Sequential therapeutic trials for catatonoid frontal signs in clinically-evident frontotemporal dementia (n = 2) revealed differential benefits for lorazepam, amantadine, memantine, pramipexole, aripiprazole, quetiapine, citalopram, and donepezil, although certain signs also worsened." | 3.76 | Differential pharmacological responses of catatonia-like signs in frontotemporal dementia. ( Greenway, LL; Kuppuswamy, PS; Lauterbach, EC, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, A | 1 |
| Todd, S | 1 |
| Finn, DP | 1 |
| McClean, PL | 1 |
| Wong-Lin, K | 1 |
| Kimura, T | 1 |
| Takamatsu, J | 1 |
| Arciniegas, DB | 1 |
| Anderson, CA | 1 |
| Lauterbach, EC | 1 |
| Kuppuswamy, PS | 1 |
| Greenway, LL | 1 |
4 other studies available for donepezil and DDPAC
| Article | Year |
|---|---|
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Depression; Donepezil; Dothiepin | 2022 |
Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms.
Topics: Apathy; Behavioral Symptoms; Delusions; Donepezil; Follow-Up Studies; Frontotemporal Dementia; Human | 2013 |
Donepezil-induced confusional state in a patient with autopsy-proven behavioral-variant frontotemporal dementia.
Topics: Adult; Behavioral Symptoms; Cholinesterase Inhibitors; Confusion; Donepezil; Frontotemporal Dementia | 2013 |
Differential pharmacological responses of catatonia-like signs in frontotemporal dementia.
Topics: Aged; Amantadine; Antipsychotic Agents; Aripiprazole; Benzothiazoles; Catatonia; Citalopram; Clinica | 2010 |